Dhanuka Agritech Ltd., a player in India’s agricultural input sector, has secured the international rights to the active ingredients iprovalicarb and triadimenol.
The move is a strategic step towards broadening the company’s global presence, enabling expansion into over 20 countries across regions such as Latin America (LATAM), Europe, the Middle East, and Africa (EMEA), as well as Asia, including India.
Strengthening Global Market Position
The acquisition provides Dhanuka with exclusive rights to manufacture and sell iprovalicarb and triadimenol worldwide.
Additionally, the company will take ownership of the melody brand for iprovalicarb, including its sub-brands such as melody duo, melody compact, and melodika.
This marks a significant milestone in Dhanuka’s strategy to expand its global footprint.
Transition Plan for Seamless Service
As part of the agreement, Dhanuka and Bayer AG have outlined a detailed transition plan to ensure a smooth handover of services.
This will guarantee uninterrupted support for growers and customers worldwide during the changeover.
Moreover, Dhanuka plans to shift the manufacturing of at least one of these products to India, utilizing its advanced manufacturing unit at Dahej, Gujarat.
Commitment to Strategic Growth
Harsh Dhanuka, Executive Director of Dhanuka Agritech Ltd. commented, “We are excited to embark on this journey with Bayer AG as we expand our footprint in these key markets. This agreement not only strengthens our market presence but also underscores our commitment to delivering exceptional products and services to customers globally.”
As reported by krishijagran.com, he further emphasized that the acquisition aligns with Dhanuka’s ongoing focus on strategic growth and maintaining strong relationships with stakeholders, ensuring long-term value for growers worldwide.
